MITOLA, STEFANIA MARIA FILOMENA
 Distribuzione geografica
Continente #
NA - Nord America 12.028
EU - Europa 9.435
AS - Asia 6.131
SA - Sud America 1.051
Continente sconosciuto - Info sul continente non disponibili 383
AF - Africa 146
OC - Oceania 90
Totale 29.264
Nazione #
US - Stati Uniti d'America 11.776
PL - Polonia 5.079
CN - Cina 2.003
SG - Singapore 1.942
IT - Italia 1.040
BR - Brasile 864
UA - Ucraina 826
DE - Germania 623
VN - Vietnam 607
HK - Hong Kong 585
FI - Finlandia 454
GB - Regno Unito 322
FR - Francia 283
IN - India 196
TR - Turchia 186
RU - Federazione Russa 171
IE - Irlanda 160
BD - Bangladesh 152
CA - Canada 123
ID - Indonesia 103
AU - Australia 84
ES - Italia 77
NL - Olanda 72
SE - Svezia 72
AR - Argentina 69
MX - Messico 66
ZA - Sudafrica 50
BE - Belgio 49
IQ - Iraq 49
CZ - Repubblica Ceca 46
JP - Giappone 46
AT - Austria 31
EC - Ecuador 28
PK - Pakistan 28
VE - Venezuela 23
CL - Cile 21
MA - Marocco 21
SA - Arabia Saudita 21
UZ - Uzbekistan 20
NG - Nigeria 17
AE - Emirati Arabi Uniti 16
CH - Svizzera 16
EG - Egitto 16
JM - Giamaica 16
TW - Taiwan 16
CO - Colombia 15
GR - Grecia 15
IR - Iran 15
MY - Malesia 15
JO - Giordania 14
KR - Corea 13
DZ - Algeria 12
IL - Israele 12
PH - Filippine 12
PY - Paraguay 12
AZ - Azerbaigian 11
KE - Kenya 11
LT - Lituania 11
EE - Estonia 9
BG - Bulgaria 8
HU - Ungheria 8
KG - Kirghizistan 8
NO - Norvegia 8
NP - Nepal 8
AL - Albania 7
EU - Europa 7
HN - Honduras 7
KZ - Kazakistan 7
PE - Perù 7
RO - Romania 7
UY - Uruguay 7
CR - Costa Rica 6
DK - Danimarca 6
DO - Repubblica Dominicana 6
LK - Sri Lanka 6
OM - Oman 6
PA - Panama 6
SK - Slovacchia (Repubblica Slovacca) 6
TH - Thailandia 6
ET - Etiopia 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
BB - Barbados 4
BO - Bolivia 4
BY - Bielorussia 4
GT - Guatemala 4
LA - Repubblica Popolare Democratica del Laos 4
MO - Macao, regione amministrativa speciale della Cina 4
PT - Portogallo 4
SV - El Salvador 4
AM - Armenia 3
HR - Croazia 3
LV - Lettonia 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
KW - Kuwait 2
LB - Libano 2
LC - Santa Lucia 2
Totale 28.854
Città #
Warsaw 5.073
Ashburn 1.200
Fairfield 1.087
Singapore 1.049
Woodbridge 719
Houston 687
San Jose 660
Jacksonville 612
Hong Kong 579
Ann Arbor 495
Brescia 465
Seattle 451
Cambridge 421
Beijing 393
Chandler 385
Wilmington 364
Council Bluffs 309
Princeton 279
Helsinki 277
New York 275
The Dalles 270
Dong Ket 241
Los Angeles 221
Nanjing 199
Dearborn 198
Dublin 154
Dallas 149
Lauterbourg 144
Istanbul 142
Columbus 125
Munich 120
Ho Chi Minh City 119
Milan 111
São Paulo 103
Santa Clara 100
Shanghai 88
Buffalo 87
Jakarta 81
Nanchang 77
Des Moines 75
San Francisco 75
Chicago 70
Hanoi 70
Jinan 70
Phoenix 68
Shenyang 65
Changsha 63
Turku 60
Hebei 59
Orem 57
Hangzhou 55
Moscow 54
Madrid 51
San Diego 50
London 48
Brussels 46
Redondo Beach 45
Brooklyn 39
Toronto 38
Boardman 37
Jiaxing 37
Tianjin 36
Tokyo 35
Chennai 34
Guangzhou 34
Frankfurt am Main 32
Atlanta 31
Melbourne 31
Stockholm 31
Amsterdam 30
Kunming 30
Rome 30
Denver 29
Johannesburg 29
Montreal 29
Zhengzhou 29
Nuremberg 28
Haikou 27
Porto Alegre 27
Lancaster 26
Rio de Janeiro 26
Lappeenranta 25
Boston 24
Mexico City 23
Washington 23
Manchester 22
Ningbo 22
Poplar 21
Brno 20
Da Nang 20
Springfield 20
Curitiba 19
Dhaka 19
Lanzhou 19
San Mateo 19
Ankara 18
Olomouc 18
Tashkent 18
Verona 18
Abuja 17
Totale 20.730
Nome #
Tumor angiogenesis revisited: Regulators and clinical implications 443
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 404
Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. 403
Annexin 2A sustains glioblastoma cell dissemination and proliferation. 375
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. 362
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 328
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 320
A study on the VEGFR2-ligand multi-physics interactions in Angiogenesis. 319
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 310
Multi-physics interactions drive VEGFR2 relocation on endothelial cells. 308
Nanoliter contact angle probes tumor angiogenic ligand-receptor protein interactions 307
Cortical Structure Alterations and Social Behavior Impairment in p50-Deficient Mice 307
Activation of diacylglycerol kinase alpha is required for VEGF-induced angiogenic signaling in vitro. 299
Claudin3 is localized outside the tight junctions in human carcinomas 298
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 295
Regulation of dendritic cell migration and adaptive immune response by leukotriene b4 receptors: a role for LTB4 in up-regulation of CCR7 expression and function 295
Anti-angiogenic activity of the flavonoid precursor 4-hydroxychalcone. 293
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. 290
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 288
The COOH-Terminal Peptide of Platelet Factor-4 Variant (CXCL4L1/PF-4var47-70) Strongly Inhibits Angiogenesis and Suppresses B16 Melanoma Growth In vivo. 286
Modeling and Simulation of VEGF Receptors Recruitment in Angiogenesis 283
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 282
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 281
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 280
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 276
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 274
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 273
Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells. 272
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 266
Integrins: A flexible platform for endothelial vascular tyrosine kinase receptors. 262
Modulation of angiogenesis by a tetrameric tripeptide that antagonizes vascular endothelial growth factor receptor 1 260
TR-644 a novel potent tubulin binding agent induces impairment of endothelial cells function and inhibits angiogenesis. 258
Interactions between endothelial cells and HIV-1. 256
IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk. 255
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 254
IL-12-dependent innate immunity arrests endothelial cells in G0-G1 phase by a p21(Cip1/Waf1)-mediated mechanism. 251
Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34(+) cells. 251
Involvement of chemokine receptor4/ cell-derived factor 1 system during osteosarcoma tumor progression 245
Acetate intolerance is mediated by enhanced synthesis of nitric oxide by endothelial cells. 243
Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. 239
Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase-dependent mechanism 1. 232
Sialic acid associated to αvβ3 integrin mediates HIV-1 Tat interaction and endothelial cell proangiogenic activation. 232
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 231
Nitric oxide modulates the angiogenic phenotype of middle-T transformed endothelial cells. 230
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 229
Dynamic modules and heterogeneity of function: a lesson from tyrosine kinase receptors in endothelial cells. 229
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. 222
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 222
Cu(II) and Zn(II) complexes with hyaluronic acid and its sulphated derivative.Effect on the motility of vascular endothelial cells. 221
A tool for the quantification of radial neo-vessels in chick chorioallantoic membrane angiogenic assays 218
Preliminary observations on scleral ossicles in performing functionalized 3D vascularized scaffolds for “critical-size” bone defect healing 217
A Pro-inflammatory Signature Mediates FGF2-induced Angiogenesis 211
d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3 211
Silencing of pantothenate kinase 2 reduces endothelial cell angiogenesis 207
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma. 206
CEACAM1/VEGF cross-talk during neuroblastic tumour differentiation 200
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation 199
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 197
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 197
Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. 192
A Model of Integrin and VEGF Receptors Recruitment on Endothelial Cells 189
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 188
Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma 188
Atypical chemokine receptor 3 generates guidance cues for CXCL12-mediated endothelial cell migration 187
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 186
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 181
H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis 180
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 178
Bartonella henselae Persistence within Mesenchymal Stromal Cells Enhances Endothelial Cells Activation and Infectability Amplifying the Angiogenic Process 175
VEGFR2(R1051Q) and FGFR1(D647N) correspondent mutations exhibit pro-oncogenic effects both in vitro and in vivo 170
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis 168
A novel VEGFR2 mutation has oncogenic potential in BRAF wild type melanoma 167
Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy 166
Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process 165
Co-designed experiments and multi-physics modeling of the VEGFR-2 relocation on endothelial cells. 163
Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells. 162
Biosafe inertization of municipal solid waste incinerator residues by COSMOS technology. 162
The Ferritin-Heavy-Polypeptide-Like-17 (FTHL17) gene encodes a ferritin with low stability and no ferroxidase activity and with a partial nuclear localization 161
Insights on the receptor dynamics during the spreading of endothelial cells 161
Hot spot mutation in receptor tyrosine kinases elicits pro-oncogenic effects 160
IL-12 regulates an endothelial cell-lymphocyte network: effect on metalloproteinase-9 production. 152
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 149
Evaluation of Paracellular Permeability in VEGFR2 Mutants Patient-Derived Organoid 149
Human immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant production. 148
CCL16 activates an angiogenic program in vascular endothelial cells 148
Simulation of VEGF receptor recruitment on ECs membrane 148
Vascular disrupting activity of combretastatin analogues 148
Design, Synthesis, in Vitro and in Vivo Anticancer and Antiangiogenic Activity of Novel 3-Arylamino Benzofuran Derivatives Targeting the Colchicine Site on Tubulin 147
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 147
Fibroblast growth factor-2 in angiogenesis 146
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 146
Gremlin as a novel pro-angiogenic VEGFR2 agonist: production of a biologically active recombinant form in S2 Drosophila cells 144
cAMP-response element-binding protein (CREB) mediates the pro-angiogenic/inflammatory activity of gremlin. 144
Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis. 144
A mechano-biological model of the coupling between cellular con- tractility and VEGFR2/VEGF interactions. 143
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 142
A novel VEGFR2 mutation has oncogenic potential in BRAF wild-type melanoma 141
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 141
Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives 141
Insulin-like growth factor binding protein-3 is overexpressed in endothelial cells of mouse breast tumor vessels 140
Totale 22.459
Categoria #
all - tutte 112.854
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.854


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.210 0 244 27 28 37 69 74 72 67 176 103 313
2022/20231.191 198 78 61 69 90 276 22 103 166 15 42 71
2023/20241.607 85 71 154 124 91 243 60 101 295 119 40 224
2024/20253.248 69 25 38 485 363 252 291 141 394 200 572 418
2025/20267.841 650 851 527 1.002 759 535 1.253 372 575 759 401 157
2026/2027624 373 251 0 0 0 0 0 0 0 0 0 0
Totale 29.264